Back to KEYBANK NATIONAL ASSOCIATION/OH KEYBANK NATIONAL ASSOCIATION/OH

VKTXVKTX
4 quarters

Position history for KEYBANK NATIONAL ASSOCIATION/OHKEYBANK NATIONAL ASSOCIATION/OH's holdings in VIKING THERAPEUTICS INC

No. KeyBank exited its VKTX (Viking Therapeutics) position in Q3 2022. Its Q2 2022 13F listed 28,000 shares worth $81,000. KeyBank first reported VKTX in Q4 2021 and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$129,000

Total Shares Change

-28,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2022-Q3
Latest
Exited
0
-100.0%
$00.0%$2.72
0
2022-Q2
Unchanged
28,000
0.0%
$81,0000.0%$2.89
0
2022-Q1
Unchanged
28,000
0.0%
$84,0000.0%$3.00
0
2021-Q4
New
28,000
-
$129,0000.0%$4.60
31

Other major holders of VKTX: FMR LLC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used